Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Correlation analysis of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside uptake distributions in lung tumours during radiation therapy.

Di Perri D, Lee JA, Bol A, Hanin FX, Janssens G, Labar D, Robert A, Sterpin E, Geets X.

Acta Oncol. 2017 May 24:1-8. doi: 10.1080/0284186X.2017.1329594. [Epub ahead of print]

PMID:
28537761
2.

18F-Fluoroform: a 18F-trifluoromethylating agent for the synthesis of SCF218F-aromatic derivatives.

Carbonnel E, Besset T, Poisson T, Labar D, Pannecoucke X, Jubault P.

Chem Commun (Camb). 2017 May 25;53(42):5706-5709. doi: 10.1039/c7cc02652h. Epub 2017 May 12.

PMID:
28497143
3.

Evolution of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside PET uptake distributions in lung tumours during radiation therapy.

Di Perri D, Lee JA, Bol A, Hanin FX, Janssens G, Labar D, Robert A, Sterpin E, Geets X.

Acta Oncol. 2017 Apr;56(4):516-524. doi: 10.1080/0284186X.2017.1287943. Epub 2017 Feb 22.

PMID:
28358668
4.

Radiosynthesis and validation of (±)-[18F]-3-fluoro-2-hydroxypropionate ([18F]-FLac) as a PET tracer of lactate to monitor MCT1-dependent lactate uptake in tumors.

Van Hée VF, Labar D, Dehon G, Grasso D, Grégoire V, Muccioli GG, Frédérick R, Sonveaux P.

Oncotarget. 2017 Apr 11;8(15):24415-24428. doi: 10.18632/oncotarget.14705.

5.

DW-MRI and (18) F-FLT PET for early assessment of response to radiation therapy associated with hypoxia-driven interventions. Preclinical studies using manipulation of oxygenation and/or dose escalation.

Tran LB, Bol A, Labar D, Karroum O, Mignion L, Bol V, Jordan BF, Grégoire V, Gallez B.

Contrast Media Mol Imaging. 2016 Mar-Apr;11(2):115-21. doi: 10.1002/cmmi.1670. Epub 2015 Oct 7.

PMID:
27041693
6.

Long-Term Distributed Repetitive Transcranial Magnetic Stimulation for Tinnitus: A Feasibility Study.

Labar D, Labar AS, Edwards D.

Neuromodulation. 2016 Apr;19(3):249-53. doi: 10.1111/ner.12390. Epub 2016 Jan 27.

PMID:
26817797
7.

Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy.

Salanova V, Witt T, Worth R, Henry TR, Gross RE, Nazzaro JM, Labar D, Sperling MR, Sharan A, Sandok E, Handforth A, Stern JM, Chung S, Henderson JM, French J, Baltuch G, Rosenfeld WE, Garcia P, Barbaro NM, Fountain NB, Elias WJ, Goodman RR, Pollard JR, Tröster AI, Irwin CP, Lambrecht K, Graves N, Fisher R; SANTE Study Group..

Neurology. 2015 Mar 10;84(10):1017-25. doi: 10.1212/WNL.0000000000001334. Epub 2015 Feb 6.

8.

Predictive value of (18)F-FAZA PET imaging for guiding the association of radiotherapy with nimorazole: a preclinical study.

Tran LB, Bol A, Labar D, Cao-Pham TT, Jordan B, Grégoire V, Gallez B.

Radiother Oncol. 2015 Feb;114(2):189-94. doi: 10.1016/j.radonc.2014.12.015. Epub 2015 Jan 20.

PMID:
25616539
9.

Long-term treatment with responsive brain stimulation in adults with refractory partial seizures.

Bergey GK, Morrell MJ, Mizrahi EM, Goldman A, King-Stephens D, Nair D, Srinivasan S, Jobst B, Gross RE, Shields DC, Barkley G, Salanova V, Olejniczak P, Cole A, Cash SS, Noe K, Wharen R, Worrell G, Murro AM, Edwards J, Duchowny M, Spencer D, Smith M, Geller E, Gwinn R, Skidmore C, Eisenschenk S, Berg M, Heck C, Van Ness P, Fountain N, Rutecki P, Massey A, O'Donovan C, Labar D, Duckrow RB, Hirsch LJ, Courtney T, Sun FT, Seale CG.

Neurology. 2015 Feb 24;84(8):810-7. doi: 10.1212/WNL.0000000000001280. Epub 2015 Jan 23.

10.

Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study.

Servagi-Vernat S, Differding S, Sterpin E, Hanin FX, Labar D, Bol A, Lee JA, Grégoire V.

Acta Oncol. 2015 Jul;54(7):1008-16. doi: 10.3109/0284186X.2014.990109. Epub 2015 Jan 6.

PMID:
25562382
11.

Intensity dependent effects of transcranial direct current stimulation on corticospinal excitability in chronic spinal cord injury.

Murray LM, Edwards DJ, Ruffini G, Labar D, Stampas A, Pascual-Leone A, Cortes M.

Arch Phys Med Rehabil. 2015 Apr;96(4 Suppl):S114-21. doi: 10.1016/j.apmr.2014.11.004. Epub 2014 Nov 22.

12.

Potential role of hypoxia imaging using (18)F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy.

Tran LB, Bol A, Labar D, Karroum O, Bol V, Jordan B, Grégoire V, Gallez B.

Radiother Oncol. 2014 Nov;113(2):204-9. doi: 10.1016/j.radonc.2014.09.016. Epub 2014 Nov 27.

PMID:
25434767
13.

Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation.

Bol V, Bol A, Bouzin C, Labar D, Lee JA, Janssens G, Porporato PE, Sonveaux P, Feron O, Grégoire V.

Acta Oncol. 2015 Feb;54(2):266-74. doi: 10.3109/0284186X.2014.932006. Epub 2014 Jul 9.

PMID:
25007226
14.

[(18) F]CuCF3 : a [(18) F]trifluoromethylating agent for arylboronic acids and aryl iodides.

Ivashkin P, Lemonnier G, Cousin J, Grégoire V, Labar D, Jubault P, Pannecoucke X.

Chemistry. 2014 Jul 28;20(31):9514-8. doi: 10.1002/chem.201403630. Epub 2014 Jun 24.

PMID:
24957875
15.

A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy.

Servagi-Vernat S, Differding S, Hanin FX, Labar D, Bol A, Lee JA, Grégoire V.

Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1544-52. doi: 10.1007/s00259-014-2730-x. Epub 2014 Feb 26.

PMID:
24570097
16.

(89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy.

Karmani L, Bouchat V, Bouzin C, Levêque P, Labar D, Bol A, Deumer G, Marega R, Bonifazi D, Haufroid V, Michiels C, Grégoire V, Feron O, Lucas S, Vander Borght T, Gallez B.

Nanomedicine (Lond). 2014 Sep;9(13):1923-37. doi: 10.2217/nnm.13.185. Epub 2014 Feb 18.

PMID:
24547782
17.

Effects of responsive electrical brain stimulation on intracranial electroencephalogram spikes.

Labar D, Dakov P, Kobylarz E, Nikolov B, Schwartz TH, Fisher S.

Neuromodulation. 2013 Jul-Aug;16(4):355-61; discussion 362. doi: 10.1111/ner.12039.

PMID:
24028274
18.

Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice.

Karmani L, Labar D, Valembois V, Bouchat V, Nagaswaran PG, Bol A, Gillart J, Levêque P, Bouzin C, Bonifazi D, Michiels C, Feron O, Grégoire V, Lucas S, Vander Borght T, Gallez B.

Contrast Media Mol Imaging. 2013 Sep-Oct;8(5):402-8. doi: 10.1002/cmmi.1539.

PMID:
23740810
19.

Synthesis of new 18F-radiolabeled silicon-based nitroimidazole compounds.

Joyard Y, Azzouz R, Bischoff L, Papamicaël C, Labar D, Bol A, Bol V, Vera P, Grégoire V, Levacher V, Bohn P.

Bioorg Med Chem. 2013 Jul 1;21(13):3680-8. doi: 10.1016/j.bmc.2013.04.029. Epub 2013 Apr 22.

PMID:
23665140
20.

Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion-weighted MRI, choline spectroscopy and 18F-FLT PET imaging.

Karroum O, Mignion L, Kengen J, Karmani L, Levêque P, Danhier P, Magat J, Bol A, Labar D, Grégoire V, Bouzin C, Feron O, Gallez B, Jordan BF.

Contrast Media Mol Imaging. 2013 May-Jun;8(3):274-80. doi: 10.1002/cmmi.1525.

PMID:
23606431

Supplemental Content

Loading ...
Support Center